CA2945137C - Soins holistiques a dispenser a un patient dans un hopital et systeme de gestion et procede de surveillance automatisee de patient - Google Patents
Soins holistiques a dispenser a un patient dans un hopital et systeme de gestion et procede de surveillance automatisee de patient Download PDFInfo
- Publication number
- CA2945137C CA2945137C CA2945137A CA2945137A CA2945137C CA 2945137 C CA2945137 C CA 2945137C CA 2945137 A CA2945137 A CA 2945137A CA 2945137 A CA2945137 A CA 2945137A CA 2945137 C CA2945137 C CA 2945137C
- Authority
- CA
- Canada
- Prior art keywords
- patient
- data
- clinical
- patients
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012544 monitoring process Methods 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 124
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 98
- 201000010099 disease Diseases 0.000 claims description 97
- 230000008569 process Effects 0.000 claims description 60
- 238000007726 management method Methods 0.000 claims description 46
- 238000011282 treatment Methods 0.000 claims description 44
- 230000036541 health Effects 0.000 claims description 38
- 230000002411 adverse Effects 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 20
- 230000008859 change Effects 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 15
- 238000013473 artificial intelligence Methods 0.000 claims description 13
- 230000004044 response Effects 0.000 claims description 12
- 238000003058 natural language processing Methods 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 5
- 208000011117 substance-related disease Diseases 0.000 claims description 5
- 206010020751 Hypersensitivity Diseases 0.000 claims description 4
- 208000026935 allergic disease Diseases 0.000 claims description 4
- 230000007815 allergy Effects 0.000 claims description 4
- 235000005911 diet Nutrition 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 238000012800 visualization Methods 0.000 claims description 4
- 230000003542 behavioural effect Effects 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 230000002068 genetic effect Effects 0.000 claims description 3
- 238000003384 imaging method Methods 0.000 claims description 3
- 230000003340 mental effect Effects 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- 238000002255 vaccination Methods 0.000 claims description 3
- 230000000378 dietary effect Effects 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 description 35
- 208000028659 discharge Diseases 0.000 description 32
- 206010007559 Cardiac failure congestive Diseases 0.000 description 28
- 238000004458 analytical method Methods 0.000 description 26
- 238000004088 simulation Methods 0.000 description 22
- 230000006870 function Effects 0.000 description 19
- 238000004891 communication Methods 0.000 description 16
- 238000010586 diagram Methods 0.000 description 16
- 238000002560 therapeutic procedure Methods 0.000 description 16
- 238000001356 surgical procedure Methods 0.000 description 15
- 238000003745 diagnosis Methods 0.000 description 13
- 230000000474 nursing effect Effects 0.000 description 12
- 208000007474 aortic aneurysm Diseases 0.000 description 11
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 10
- 206010000891 acute myocardial infarction Diseases 0.000 description 10
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 238000013439 planning Methods 0.000 description 7
- 238000012552 review Methods 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000001815 facial effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000003466 anti-cipated effect Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 229940109239 creatinine Drugs 0.000 description 5
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 5
- 229940063711 lasix Drugs 0.000 description 5
- 230000008520 organization Effects 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 206010003658 Atrial Fibrillation Diseases 0.000 description 4
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 4
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 description 4
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 description 4
- 208000010496 Heart Arrest Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 102000004903 Troponin Human genes 0.000 description 4
- 108090001027 Troponin Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 208000020832 chronic kidney disease Diseases 0.000 description 4
- 238000013075 data extraction Methods 0.000 description 4
- 238000013499 data model Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000002638 palliative care Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000013468 resource allocation Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 208000002333 Asphyxia Neonatorum Diseases 0.000 description 3
- 206010007617 Cardio-respiratory arrest Diseases 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 3
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 238000009223 counseling Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 208000033300 perinatal asphyxia Diseases 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 230000001179 pupillary effect Effects 0.000 description 3
- 230000004043 responsiveness Effects 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 238000013517 stratification Methods 0.000 description 3
- 229960000187 tissue plasminogen activator Drugs 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 2
- 206010051055 Deep vein thrombosis Diseases 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 206010052337 Diastolic dysfunction Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000000770 Non-ST Elevated Myocardial Infarction Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000010378 Pulmonary Embolism Diseases 0.000 description 2
- 206010047249 Venous thrombosis Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000013503 de-identification Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000012913 prioritisation Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 238000012384 transportation and delivery Methods 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 206010000372 Accident at work Diseases 0.000 description 1
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010068819 Conjunctival pallor Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010022773 Intracranial pressure increased Diseases 0.000 description 1
- 108010007859 Lisinopril Proteins 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- YGULWPYYGQCFMP-CEAXSRTFSA-N Metoprolol tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 YGULWPYYGQCFMP-CEAXSRTFSA-N 0.000 description 1
- 102100036836 Natriuretic peptides B Human genes 0.000 description 1
- 101710187802 Natriuretic peptides B Proteins 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 238000012896 Statistical algorithm Methods 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 102000013394 Troponin I Human genes 0.000 description 1
- 108010065729 Troponin I Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000017488 activation-induced cell death of T cell Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000011256 aggressive treatment Methods 0.000 description 1
- 238000011394 anticancer treatment Methods 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- OGHNVEJMJSYVRP-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2 OGHNVEJMJSYVRP-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229940069210 coreg Drugs 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000020785 dietary preference Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002283 elective surgery Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 1
- 229960002394 lisinopril Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 229940065778 narcan Drugs 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 238000009116 palliative therapy Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229940020573 plavix Drugs 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009430 psychological distress Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000012066 statistical methodology Methods 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/90—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to alternative medicines, e.g. homeopathy or oriental medicines
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Biomedical Technology (AREA)
- General Business, Economics & Management (AREA)
- Economics (AREA)
- Human Resources & Organizations (AREA)
- Strategic Management (AREA)
- Entrepreneurship & Innovation (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Educational Administration (AREA)
- Game Theory and Decision Science (AREA)
- Development Economics (AREA)
- Marketing (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Tourism & Hospitality (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Alarm Systems (AREA)
Abstract
La présente invention concerne des soins holistiques à dispenser à un patient dans un hôpital et un système de gestion comprenant les éléments suivants : une mémoire de données destinée à recevoir et stocker des données de patient, incluant des données cliniques et non cliniques; une pluralité de capteurs RFID pour détecter une pluralité d'étiquettes RFID associées à des patients afin de permettre un suivi de localisation en temps réel; au moins un modèle prédictif incluant une pluralité de variables de risque pondéré et de seuils de risque, compte tenu des données cliniques et non cliniques, et conçu pour identifier au moins un état médical associé aux patients; un module logique de risque conçu pour appliquer au moins un modèle prédictif aux données cliniques et non cliniques pour déterminer au moins un score de risques associé à chaque patient; un module logique de surveillance de patient conçu pour recevoir des données de localisation des patients et déterminer l'état et la localisation des patients en temps réel; et un module d'interface utilisateur conçu pour afficher la pathologie médicale du patient, le score de risque, la localisation, et les informations de statut à un personnel autorisé.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461978058P | 2014-04-10 | 2014-04-10 | |
| US61/978,058 | 2014-04-10 | ||
| PCT/US2015/025205 WO2015157575A2 (fr) | 2014-04-10 | 2015-04-09 | Soins holistiques à dispenser à un patient dans un hôpital et système de gestion et procédé de surveillance automatisée de patient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2945137A1 CA2945137A1 (fr) | 2015-10-15 |
| CA2945137C true CA2945137C (fr) | 2024-01-16 |
Family
ID=54288414
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2945138A Abandoned CA2945138A1 (fr) | 2014-04-10 | 2015-04-09 | Les soins a apporter a un patient d'hopital holistique et systeme de gestion et procede pour telemedecine |
| CA2945134A Pending CA2945134A1 (fr) | 2014-04-10 | 2015-04-09 | Systeme de gestion et de soins holistiques de patients d'un hopital et procede pour l'engagement des familles et des patients |
| CA2945136A Pending CA2945136A1 (fr) | 2014-04-10 | 2015-04-09 | Systeme de gestion et de soins holistiques pour patient d'hopital et procede de surveillance automatisee du personnel |
| CA2945137A Active CA2945137C (fr) | 2014-04-10 | 2015-04-09 | Soins holistiques a dispenser a un patient dans un hopital et systeme de gestion et procede de surveillance automatisee de patient |
| CA2945143A Active CA2945143C (fr) | 2014-04-10 | 2015-04-09 | Systeme holistique de soins et de gestion de patients d'hopital et procede de stratification des risques amelioree |
| CA2945131A Pending CA2945131A1 (fr) | 2014-04-10 | 2015-04-09 | Systeme holistique de soins de sante et de gestion de patients d'hopital et procede de gestion automatisee des ressources |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2945138A Abandoned CA2945138A1 (fr) | 2014-04-10 | 2015-04-09 | Les soins a apporter a un patient d'hopital holistique et systeme de gestion et procede pour telemedecine |
| CA2945134A Pending CA2945134A1 (fr) | 2014-04-10 | 2015-04-09 | Systeme de gestion et de soins holistiques de patients d'un hopital et procede pour l'engagement des familles et des patients |
| CA2945136A Pending CA2945136A1 (fr) | 2014-04-10 | 2015-04-09 | Systeme de gestion et de soins holistiques pour patient d'hopital et procede de surveillance automatisee du personnel |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2945143A Active CA2945143C (fr) | 2014-04-10 | 2015-04-09 | Systeme holistique de soins et de gestion de patients d'hopital et procede de stratification des risques amelioree |
| CA2945131A Pending CA2945131A1 (fr) | 2014-04-10 | 2015-04-09 | Systeme holistique de soins de sante et de gestion de patients d'hopital et procede de gestion automatisee des ressources |
Country Status (3)
| Country | Link |
|---|---|
| EP (4) | EP3129951A4 (fr) |
| CA (6) | CA2945138A1 (fr) |
| WO (6) | WO2015157575A2 (fr) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3085086C (fr) | 2011-12-06 | 2023-08-08 | Delta Faucet Company | Distribution d'ozone dans un robinet |
| US11568982B1 (en) | 2014-02-17 | 2023-01-31 | Health at Scale Corporation | System to improve the logistics of clinical care by selectively matching patients to providers |
| US11114204B1 (en) * | 2014-04-04 | 2021-09-07 | Predictive Modeling, Inc. | System to determine inpatient or outpatient care and inform decisions about patient care |
| CA3004601A1 (fr) * | 2015-11-25 | 2017-06-01 | Emopti, Inc. | Systeme de soins medicaux de courte duree |
| JP6904957B2 (ja) * | 2015-12-14 | 2021-07-21 | トライセラ インコーポレイテッド | ロバストなヘルストラッキングサービス |
| CN108463437B (zh) | 2015-12-21 | 2022-07-08 | 德尔塔阀门公司 | 包括消毒装置的流体输送系统 |
| EP3547320A4 (fr) * | 2016-05-20 | 2020-11-11 | Pulse Participações S.A. | Système et procédés associés pour réaliser une corrélation entre des données médicales et des conditions de diagnostic et d'accompagnement du traitement de santé d'un patient surveillé en temps réel |
| US20180288024A1 (en) * | 2017-03-31 | 2018-10-04 | Intel Corporation | Secure manner for sharing confidential information |
| US11348679B1 (en) * | 2017-07-12 | 2022-05-31 | Teletracking Technologies, Inc. | Systems and methods for processing real-time and historical data and generating nursing unit health scores |
| US20190156923A1 (en) | 2017-11-17 | 2019-05-23 | LunaPBC | Personal, omic, and phenotype data community aggregation platform |
| US20190180872A1 (en) * | 2017-12-12 | 2019-06-13 | International Business Machines Corporation | Second Opinion Decision Support Using Patient Electronic Medical Records |
| WO2019115465A1 (fr) * | 2017-12-15 | 2019-06-20 | Radiometer Medical Aps | Système de dispositifs médicaux |
| CN112805785A (zh) * | 2018-01-31 | 2021-05-14 | 卡尔莱特股份有限公司 | 提高患者生活质量、参与度和持续性的疾病因子的早期反馈 |
| US11908581B2 (en) | 2018-04-10 | 2024-02-20 | Hill-Rom Services, Inc. | Patient risk assessment based on data from multiple sources in a healthcare facility |
| US11504071B2 (en) | 2018-04-10 | 2022-11-22 | Hill-Rom Services, Inc. | Patient risk assessment based on data from multiple sources in a healthcare facility |
| EP3573068A1 (fr) * | 2018-05-24 | 2019-11-27 | Siemens Healthcare GmbH | Système et procédé pour un système de support de décisions cliniques automatisé |
| WO2019227097A1 (fr) * | 2018-05-25 | 2019-11-28 | Green, Nicholas | Systèmes et procédés de fourniture d'informations d'identité |
| EP3890598A4 (fr) * | 2018-12-07 | 2022-07-27 | Emory University | Collecte passive de données et utilisation de modèles d'apprentissage automatique pour la prédiction d'événements |
| JP2022523621A (ja) | 2018-12-28 | 2022-04-26 | ルナピービーシー | コミュニティデータの集約、完成、修正、および使用 |
| CN110010240A (zh) * | 2019-04-01 | 2019-07-12 | 安徽九翔信息科技有限责任公司 | 一种医疗机构信息云计算服务平台 |
| US11315056B2 (en) * | 2019-04-05 | 2022-04-26 | International Business Machines Corporation | Resource planning having improved visualization |
| CN111009322B (zh) * | 2019-10-21 | 2022-08-02 | 四川大学华西医院 | 围术期风险评估和临床决策智能辅助系统 |
| US11468381B1 (en) * | 2019-12-02 | 2022-10-11 | Sallen Llc | System and method for virtual cloud-based facilitation of homelessness reduction through secure, scalable, real-time need assessment and resource availability tracking and allocation |
| US11610679B1 (en) | 2020-04-20 | 2023-03-21 | Health at Scale Corporation | Prediction and prevention of medical events using machine-learning algorithms |
| US11915570B2 (en) | 2020-07-16 | 2024-02-27 | Ventec Life Systems, Inc. | System and method for concentrating gas |
| CN116322936A (zh) | 2020-07-16 | 2023-06-23 | 英瓦卡尔公司 | 用于浓缩气体的系统和方法 |
| CN113592238A (zh) * | 2021-07-01 | 2021-11-02 | 浪潮软件股份有限公司 | 一种基于大数据的监管养老机构的方法 |
| WO2023281425A1 (fr) * | 2021-07-09 | 2023-01-12 | Ayur.Ai (Opc) Private Limited | Kiosque numérique pour effectuer une analyse intégrative de la santé et d'une pathologie et méthode associée |
| CN113724845B (zh) * | 2021-08-30 | 2023-06-23 | 深圳平安智慧医健科技有限公司 | 基于人工智能的医护人员配比检测方法及相关装置 |
| CN113851210A (zh) * | 2021-10-15 | 2021-12-28 | 威海市立医院 | 一种医院设备定位管理系统 |
| WO2024037796A1 (fr) * | 2022-08-15 | 2024-02-22 | Biotronik Ag | Système numérique pour l'admission et/ou le traitement par ordre de priorité d'un patient |
| EP4343789A1 (fr) * | 2022-09-23 | 2024-03-27 | Koninklijke Philips N.V. | Procédés et systèmes d'optimisation de sortie de patient à l'aide d'une probabilité de montée |
| CN115662598B (zh) * | 2022-12-27 | 2023-04-07 | 深圳市全息医疗科技有限公司 | 一种基于医院数据资源的管理智慧化质量提升系统 |
| CN116919361A (zh) * | 2023-09-06 | 2023-10-24 | 广东省建科建筑设计院有限公司 | 基于物联网实现负压病房下的电气智能控制方法及系统 |
| CN117275692A (zh) * | 2023-09-25 | 2023-12-22 | 苏州仲如悦科技有限责任公司 | 一种基于大数据的医疗资源优化配置方法及系统 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7860725B2 (en) * | 1998-05-26 | 2010-12-28 | Ineedmd.Com, Inc. | Method for remote medical consultation and care |
| US20070156456A1 (en) * | 2006-01-04 | 2007-07-05 | Siemens Medical Solutions Health Services Corporation | System for Monitoring Healthcare Related Activity In A Healthcare Enterprise |
| US8684922B2 (en) * | 2006-05-12 | 2014-04-01 | Bao Tran | Health monitoring system |
| US20080164998A1 (en) * | 2007-01-05 | 2008-07-10 | Siemens Medical Solutions Usa, Inc. | Location Sensitive Healthcare Task Management System |
| US20100017225A1 (en) * | 2008-07-18 | 2010-01-21 | WAVi | Diagnostician customized medical diagnostic apparatus using a digital library |
| US8381124B2 (en) * | 2008-07-30 | 2013-02-19 | The Regents Of The University Of California | Single select clinical informatics |
| US20140167917A2 (en) * | 2008-12-08 | 2014-06-19 | Infonaut, Inc. | Disease Mapping and Infection Control System and Method |
| WO2010108092A2 (fr) * | 2009-03-19 | 2010-09-23 | Phenotypeit, Inc. | Système médical d'information sur la santé |
| US20110077972A1 (en) * | 2009-09-24 | 2011-03-31 | Agneta Breitenstein | Systems and methods of clinical tracking |
| CN103189883A (zh) * | 2010-09-07 | 2013-07-03 | 里兰斯坦福初级大学理事会 | 医学评分系统及方法 |
| US20120078661A1 (en) * | 2010-09-28 | 2012-03-29 | Scan Am Company | Health Care Facility Management and Information System |
| US8515777B1 (en) * | 2010-10-13 | 2013-08-20 | ProcessProxy Corporation | System and method for efficient provision of healthcare |
| US9536052B2 (en) * | 2011-10-28 | 2017-01-03 | Parkland Center For Clinical Innovation | Clinical predictive and monitoring system and method |
| US9075909B2 (en) * | 2011-11-20 | 2015-07-07 | Flurensics Inc. | System and method to enable detection of viral infection by users of electronic communication devices |
| EP2896015A4 (fr) * | 2012-09-13 | 2016-04-20 | Parkland Ct For Clinical Innovation | Système et procédé d'interface utilisateur pour tableau de bord clinique |
| US9147041B2 (en) * | 2012-09-13 | 2015-09-29 | Parkland Center For Clinical Innovation | Clinical dashboard user interface system and method |
-
2015
- 2015-04-09 EP EP15777492.8A patent/EP3129951A4/fr not_active Withdrawn
- 2015-04-09 WO PCT/US2015/025205 patent/WO2015157575A2/fr active Application Filing
- 2015-04-09 EP EP15777433.2A patent/EP3129945A4/fr not_active Withdrawn
- 2015-04-09 WO PCT/US2015/025206 patent/WO2015157576A1/fr active Application Filing
- 2015-04-09 CA CA2945138A patent/CA2945138A1/fr not_active Abandoned
- 2015-04-09 CA CA2945134A patent/CA2945134A1/fr active Pending
- 2015-04-09 WO PCT/US2015/025207 patent/WO2015157577A2/fr active Application Filing
- 2015-04-09 EP EP15777472.0A patent/EP3129950A4/fr not_active Withdrawn
- 2015-04-09 CA CA2945136A patent/CA2945136A1/fr active Pending
- 2015-04-09 WO PCT/US2015/025203 patent/WO2015157573A2/fr active Application Filing
- 2015-04-09 WO PCT/US2015/025202 patent/WO2015157572A1/fr active Application Filing
- 2015-04-09 EP EP15776758.3A patent/EP3129949A4/fr not_active Withdrawn
- 2015-04-09 CA CA2945137A patent/CA2945137C/fr active Active
- 2015-04-09 CA CA2945143A patent/CA2945143C/fr active Active
- 2015-04-09 CA CA2945131A patent/CA2945131A1/fr active Pending
- 2015-04-09 WO PCT/US2015/025200 patent/WO2015157570A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP3129945A4 (fr) | 2018-01-24 |
| EP3129951A4 (fr) | 2018-01-10 |
| CA2945137A1 (fr) | 2015-10-15 |
| WO2015157577A2 (fr) | 2015-10-15 |
| EP3129949A4 (fr) | 2018-01-03 |
| EP3129950A2 (fr) | 2017-02-15 |
| WO2015157575A2 (fr) | 2015-10-15 |
| WO2015157576A1 (fr) | 2015-10-15 |
| CA2945138A1 (fr) | 2015-10-15 |
| WO2015157573A3 (fr) | 2015-12-03 |
| EP3129949A2 (fr) | 2017-02-15 |
| WO2015157577A3 (fr) | 2015-12-03 |
| EP3129950A4 (fr) | 2018-01-03 |
| WO2015157570A1 (fr) | 2015-10-15 |
| EP3129951A1 (fr) | 2017-02-15 |
| CA2945134A1 (fr) | 2015-10-15 |
| CA2945143A1 (fr) | 2015-10-15 |
| CA2945131A1 (fr) | 2015-10-15 |
| CA2945136A1 (fr) | 2015-10-15 |
| WO2015157575A3 (fr) | 2015-12-03 |
| CA2945143C (fr) | 2023-08-08 |
| WO2015157572A1 (fr) | 2015-10-15 |
| WO2015157573A2 (fr) | 2015-10-15 |
| EP3129945A1 (fr) | 2017-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2945137C (fr) | Soins holistiques a dispenser a un patient dans un hopital et systeme de gestion et procede de surveillance automatisee de patient | |
| US10496788B2 (en) | Holistic hospital patient care and management system and method for automated patient monitoring | |
| US10593426B2 (en) | Holistic hospital patient care and management system and method for automated facial biological recognition | |
| US20150213225A1 (en) | Holistic hospital patient care and management system and method for enhanced risk stratification | |
| US20150213217A1 (en) | Holistic hospital patient care and management system and method for telemedicine | |
| US20150213222A1 (en) | Holistic hospital patient care and management system and method for automated resource management | |
| US20150213202A1 (en) | Holistic hospital patient care and management system and method for patient and family engagement | |
| US20150213206A1 (en) | Holistic hospital patient care and management system and method for automated staff monitoring | |
| US20210012866A1 (en) | Client Management Tool System and Method | |
| US20150213223A1 (en) | Holistic hospital patient care and management system and method for situation analysis simulation | |
| US9147041B2 (en) | Clinical dashboard user interface system and method | |
| CA2884613C (fr) | Systeme et procede d'interface utilisateur pour tableau de bord clinique | |
| US20170061093A1 (en) | Clinical Dashboard User Interface System and Method | |
| US9536052B2 (en) | Clinical predictive and monitoring system and method | |
| US20170132371A1 (en) | Automated Patient Chart Review System and Method | |
| EP3910648A1 (fr) | Système et procédé d'outil de gestion de clients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200406 |
|
| EEER | Examination request |
Effective date: 20200406 |
|
| EEER | Examination request |
Effective date: 20200406 |
|
| EEER | Examination request |
Effective date: 20200406 |
|
| EEER | Examination request |
Effective date: 20200406 |
|
| EEER | Examination request |
Effective date: 20200406 |
|
| EEER | Examination request |
Effective date: 20200406 |